About RAMM Pharma
RAMM Pharma is a company based in Toronto (Canada) founded in 1988. It operates as a Direct-to-Consumer (D2C), and B2B2C. RAMM Pharma offers products and services including Epifractán, Xalex 10, Nettavet, Nettapet, and Marishanti. RAMM Pharma operates in a competitive market with competitors including Decibel Cannabis, Protonify and Siam Stix Ventures, among others.
- Headquarter Toronto, Canada
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ramm Pharma Corp
-
Annual Revenue
$3.12 M (USD)-14.28as on Oct 31, 2024
-
Net Profit
$-11.86 M (USD)-113.73as on Oct 31, 2024
-
EBITDA
$-3.98 M (USD)3.35as on Oct 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of RAMM Pharma
RAMM Pharma is a publicly listed company on the CSE with ticker symbol RAMM in Canada, operating in the Consumer non-durables sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of RAMM Pharma
RAMM Pharma offers a comprehensive portfolio of products and services, including Epifractán, Xalex 10, Nettavet, Nettapet, and Marishanti. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Cannabidiol-based pharmaceutical product for oral sublingual use.
Pure cannabidiol pharmaceutical for oral sublingual application.
Cannabidiol-based solution for dogs with therapeutic effects.
Balanced pet food for various life stages.
Natural cosmetic products respecting nature and environment.
Funding Insights of RAMM Pharma
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2023 | Amount | Post-IPO - RAMM Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by RAMM Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - RAMM Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ramm Pharma Comparisons
Competitors of RAMM Pharma
RAMM Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Decibel Cannabis, Protonify and Siam Stix Ventures, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cannabis products are produced and distributed by Decibel Cannabis.
|
|
| domain | founded_year | HQ Location |
Production and distribution of biological cannabinoids are conducted.
|
|
| domain | founded_year | HQ Location |
Serves as a contract manufacturer specializing in cannabis products.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ramm Pharma
Frequently Asked Questions about RAMM Pharma
When was RAMM Pharma founded?
RAMM Pharma was founded in 1988 and raised its 1st funding round 35 years after it was founded.
Where is RAMM Pharma located?
RAMM Pharma is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Who is the current CEO of RAMM Pharma?
Jack Burnett is the current CEO of RAMM Pharma.
What is the annual revenue of RAMM Pharma?
Annual revenue of RAMM Pharma is $3.12M as on Oct 31, 2024.
What does RAMM Pharma do?
RAMM Pharma is involved in the development and distribution of cannabinoid-based pharmaceutical products approved by health authorities. Operations are primarily based in Uruguay, benefiting from the countrys stable political and economic environment. The company has established distribution agreements across Latin America, targeting a vast population. Products like Epifractán and Xalex are cultivated under strict quality norms. Additionally, subsidiaries like NettaLife focus on innovative pet care solutions, while Canapar in Sicily handles high-tech cannabis extraction for cosmetic, nutraceutical, and pharmaceutical sectors. Marishanti offers natural beauty products with an environmental focus.
Who are the top competitors of RAMM Pharma?
RAMM Pharma's top competitors include Decibel Cannabis, Protonify and Siam Stix Ventures.
What products or services does RAMM Pharma offer?
RAMM Pharma offers Epifractán, Xalex 10, Nettavet, Nettapet, and Marishanti.
Is RAMM Pharma publicly traded?
Yes, RAMM Pharma is publicly traded on CSE under the ticker symbol RAMM.
What is RAMM Pharma's ticker symbol?
The ticker symbol of RAMM Pharma is RAMM on CSE.